Search results

ANSTO facilitating coordinated effort to find the nexus that leads to chronic kidney disease of unknown origin

This joint initiative at ANSTO has developed a new capability: solid surface radiolabelling to evaluate Auger emitting sources for next-generation targeted therapy.

Scientists at ANSTO characterise structures with atomic detail using probes such as x-rays, electrons, neutrons and ions.

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

ANSTO's OPAL reactor is one of the world's most advanced and reliable research reactors today. To ensure we can continue operating OPAL safely and reliably and maximise utilisation, ANSTO must regularly carry out maintenance and upgrades.

The Minerals consultancy group at ANSTO has expertise in chemical engineering, metallurgy, mineralogy, chemistry, geology, and radiation safety. We can support our client's project by providing process development services, technical review, and research.

The Titan Krios cryo-electron microscope reveals the inner workings of life at the cellular level.

Winners of the Big Ideas Competition 2021

Project Bright, the construction of eight new beamlines at ANSTO’s Australian Synchrotron has reached a milestone by achieving ‘First Light’ for the new micro-computed tomography (MCT) beamline in late NovembeR.

ANSTO has hosted its second IAEA Practical Introduction to Nuclear Forensics Regional Training Course for representatives of member countries from South-East Asia, sharing expertise on the theoretical and practical aspects of nuclear forensics to respond to incidents of nuclear or other radioactive material out of regulatory control.

Australia and Sri Lanks signs new partnership to fight chronic kidney disease.

Connect with the businesses and organisations seeking better understanding decommissioning oil and gas infrastructure and the potential impact of contaminants on marine life.

Young researcher accepted into the Australian Antarctic Science Program.

Osteoporosis is a major public health issue, and it has been estimated that total annual cost of osteoporosis/osteopenia in Australia is around $2,754 million.

ANSTO has been awarded an Athena Bronze Institution Award, acknowledging our dedication to improving workplace equality, diversity and inclusion.